GERMS: European CHMP Adopts Positive Opinion for Stribild ®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection

Friday, March 22, 2013

European CHMP Adopts Positive Opinion for Stribild ®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection

Press Releases: Gilead

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)